Brain+ CEO: “CST is becoming the standard in dementia care”
Börskollen - Aktier, fonder och ekonominyheter

Börskollen

För dig med koll på börsen

Nyhet

Brain+ CEO: “CST is becoming the standard in dementia care”

Brain+ CEO: “CST is becoming the standard in dementia care”

Brain+ is a health tech company focused on treatment and management of dementia.

Centred around Cognitive Stimulation Therapy, the company’s approach has the potential to revolutionize dementia care. CEO Kim Baden-Kristensen stopped by the BioStock Studio to talk about Brain+’s path-to-market and the future of dementia management.

Lorem ipsum dolor sit amet. Est omnis iusto eos velit nostrum et pariatur quod non. Consequuntur nemo id dolores tempora ut quis quis eum. Porro dolore rem voluptas iste. Consequuntur nemo id dolores tempora ut quis quis eum

Denna källa har få eller inga artiklar bakom betalvägg
Läs hela artikeln hos Biostock

Nyhetsbrev